España
India
Italia
대한민국
日本
My Account
My Account
Notifications
Overview
+ New Watchlist
Benzinga Edge
Benzinga Research
Benzinga Pro
Log In
Get Benzinga Pro
Data & APIs
Events
Marketfy
Premarket
Boost
Advertise
Contribute
España
India
Italia
대한민국
日本
Login
Register
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Cannabis
Cannabis Conference
Earnings
Interviews
Deals
Regulations
Psychedelics
Jobs
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Cannabis
Cannabis Conference
Earnings
Interviews
Deals
Regulations
Psychedelics
Jobs
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Recent
Markets
Comments
Close menu
Loading...
Amgen
AMGN
NASDAQ
Watchlist
Leave a Comment
Logo brought to you by Benzinga Data
Get Report
Perks
Buy
Compare Brokers
Get Report
Perks
Buy
Compare Brokers
$320.16
4.62
1.46%
At close: -
$320.16
0
0.00%
After Hours: 5:14 PM EDT
15 minutes delayed
Get Report
Comment
Q3 2024 Earnings were released on Wed Oct 30th, after the market close
The most recent conference call was at 16:30 PM, 1 day ago
Click to view past webcast
Amgen (AMGN) Forecast
News
Earnings
Amgen (AMGN) Options
Guidance
Dividends
Analyst Ratings
Insider Trades
Government Trades
Short Interest
Latest news for Amgen (NASDAQ:AMGN) Stock
Amgen Stock (NASDAQ: AMGN)
Categories: All
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
Thursday, October 31, 2024
UBS Maintains Neutral on Amgen, Lowers Price ...
Benzinga Newsdesk
Stocks Tumble, Nasdaq 100 Selloffs As Tech Giants Disappoint, Crypto Companies Plummet: What's Driving Markets Thursday?
Piero Cingari
Wednesday, October 30, 2024
Amgen Sees FY24 EPS $19.20-$20.00 Vs $19.49
Benzinga Newsdesk
Amgen Sees FY24 Revenue $33B-$33.8B Vs $33.2B...
Benzinga Newsdesk
Amgen Q3 2024 Adj EPS $5.58 Beats $5.11 Estim...
Benzinga Newsdesk
Positive Outlook For Novartis As Company Capitalizes On Growing Treatment Opportunities, Analyst Highlights
Vandana Singh
Reported Earlier, 'Novo Nordisk's Ozempic and...
Benzinga Newsdesk
Wall Street Mixed, Semiconductors Tumble As AMD Disappoints, Alphabet Rallies, SMCI Plummets: What's Driving Markets Wednesday?
Piero Cingari
Wednesday, October 23, 2024
Roche's Q3 Sales Surge Led By Ocrevus, Vabysmo, Urges Regulators To Block Novo Holdings' $16.5B Catalent Acquisition
Vandana Singh
A Closer Look at Amgen's Options Market Dynamics
Benzinga Insights
Tuesday, October 22, 2024
'Amgen To Launch US Eylea Biosimilar After Ru...
Benzinga Newsdesk
Navigating 14 Analyst Ratings For Amgen
Benzinga Insights
Cantor Fitzgerald Reiterates Overweight on Am...
Benzinga Newsdesk
Monday, October 21, 2024
TD Cowen Maintains Buy on Amgen, Raises Price...
Benzinga Newsdesk
Thursday, October 17, 2024
Looking Into Amgen's Recent Short Interest
Benzinga Insights
Bernstein Initiates Coverage On Amgen with Ou...
Benzinga Newsdesk
Tuesday, October 15, 2024
Amgen Presents Phase 3 MINT Trial Data For Up...
Benzinga Newsdesk
Monday, October 14, 2024
In-Depth Examination Of 11 Analyst Recommendations For Amgen
Benzinga Insights
Truist Securities Downgrades Amgen to Hold, R...
Benzinga Newsdesk
Friday, October 11, 2024
Novo Nordisk, Eli Lilly Could Face Downward Pressure Despite Market Dominance From Potentially 16 New Obesity Drugs: See The Names
Vandana Singh
Thursday, October 10, 2024
18 Stocks To Buy, 7 To Sell This Earnings Season: Goldman Sachs Calls It 'The Year Of The Stock Picker'
Piero Cingari
Deere, Amgen, Copart And More: CNBC's 'Final Trades'
Avi Kapoor
Wednesday, October 09, 2024
Biden Administration Unveils Plan To Provide Generic Drugs for $2 to Medicare Recipients
Vandana Singh
CNBC Halftime Report Final Trades: Copart, Am...
Benzinga Newsdesk
Tuesday, October 08, 2024
Obesity Drug Coverage Could Boost Spending By...
Benzinga Newsdesk
Monday, October 07, 2024
Barclays Maintains Equal-Weight on Amgen, Rai...
Benzinga Newsdesk
'Obesity Drugmaker Rivus Said To Weigh IPO As...
Benzinga Newsdesk
Wednesday, October 02, 2024
Federal Judge Rules Amgen Must Face Tax Liability Lawsuit That Alleges Reckless Concealment Of $10.7B Tax Bill
Vandana Singh
Monday, September 30, 2024
(AMGN) - Analyzing Amgen's Short Interest
Benzinga Insights
Friday, September 27, 2024
Cantor Fitzgerald Initiates Coverage On Amgen...
Benzinga Newsdesk
Thursday, September 26, 2024
RBC Capital Reiterates Outperform on Amgen, M...
Benzinga Newsdesk
Taiwan Semiconductor, American Tower, Trane Technologies And A Health Care Stock On CNBC's 'Final Trades'
Avi Kapoor
Wednesday, September 25, 2024
Analyst Expectations For Amgen's Future
Benzinga Insights
Amgen's Rocatinlimab Has Commercial Potential Despite Competitive Landscape, Says Goldman Sachs
Vandana Singh
Baird Reiterates Underperform on Amgen, Maint...
Benzinga Newsdesk
Amgen shares are trading lower after followin...
Benzinga Newsdesk
Amgen's Rocatinlimab Data Beats Placebo In Atopic Dermatitis Trial, But Analyst Says Data Raises Concerns Amid Competitive Market
Vandana Singh
Tuesday, September 24, 2024
Amgen Says A Second Phase 3 Clinical Trial Is...
Benzinga Newsdesk
Amgen Executive Says Experimental Drug Rocati...
Benzinga Newsdesk
Amgen's TEPEZZA Approved In Japan For Active ...
Benzinga Newsdesk
Why Is Regeneron Pharmaceuticals Stock Trading Lower On Tuesday?
Vandana Singh
Market Whales and Their Recent Bets on AMGN Options
Benzinga Insights
Monday, September 23, 2024
What the Options Market Tells Us About Amgen
Benzinga Insights
Thursday, September 19, 2024
Behind the Scenes of Amgen's Latest Options Trends
Benzinga Insights
Wednesday, September 18, 2024
10 Health Care Stocks With Whale Alerts In Today's Session
Benzinga Insights
Wednesday, September 11, 2024
UnitedHealth Follows Competitors, Replaces Humira with Lower-Cost Biosimilars
Vandana Singh
Tuesday, September 10, 2024
Terns Stock Soars on Positive Data From Phase I Study of Obesity Drug
Zacks
Monday, September 09, 2024
Amgen Presents New Data For IMDELLTRA In Smal...
Benzinga Newsdesk
Thursday, September 05, 2024
Fake Ozempic Targets Weight-Loss Market: Forged Batches An International Concern
Michael Juliano
Wednesday, September 04, 2024
MHRA Finds No Evidence Supporting Link Betwee...
Benzinga Newsdesk
Show More
Create a Watchlist
FREE: Follow your stocks and cryptocurrencies with the most actionable alerts on the internet.
Click to Get Started
People Also Watch